BRAF inhibition improves tumor recognition by the immune system

  • Donia M
  • Fagone P
  • Nicoletti F
  • et al.
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In spite of the fact that they occur at high rates, the clinical responses of BRAFV600 mutant metastatic melanoma to BRAF inhibitors are usually short-lasting, with most cases progressing within le...

Cite

CITATION STYLE

APA

Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. thor, … Svane, I. M. (2012). BRAF inhibition improves tumor recognition by the immune system. OncoImmunology, 1(9), 1476–1483. https://doi.org/10.4161/onci.21940

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free